Postremission gemtuzumab ozogamicin for elderly patients with acute myelogenous leukemia with favorable characteristics and comorbid conditions.
Posted by rob on October 28, 2010 under Uncategorized | 
Comments are off for this article
Postremission gemtuzumab ozogamicin for elderly patients with acute myelogenous leukemia with favorable characteristics and comorbid conditions.
Int J Hematol. 2010 Oct 28;
Authors: Ichikawa M, Hangaishi A, Nannya Y, Kurokawa M
PMID: 20978876 [PubMed - as supplied by publisher]